Japan's government is looking to procure more generic drugs to help relieve its healthcare budget, and Eisai intends to cash in on that shift by offering its own India-made APIs to competitors. It is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback